You are not permitted to download, save or email this image. Visit image gallery to purchase the image.
Health professionals have told the Government that allowing the sale of alcohol while ruling out potentially less-damaging "legal highs" is farcical.
Products such as Kronic will have to be proven less damaging than existing recreational drugs including alcohol and tobacco under a proposed legal-high law, say documents obtained by the Herald under the Official Information Act.
The new law, being crafted by Associate Health Minister Peter Dunne, aims to end the uncontrolled sale of untested products like Kronic.
It will establish a system under which manufacturers will pay up to about $2 million to have their substance proven "low risk".
The new system will be a world first, and the Ministry of Health has consulted widely with health professionals and agencies.
That correspondence reveals widespread support - but also some misgivings.
"The elephant in the room is perpetuated by this new regime," Professor Doug Sellman of the National Addictions Centre said in a June 5 email.
"It is quite possible that new recreational drugs that have less impact than alcohol on public health will be eliminated.
"Any recreational drug policy that doesn't include alcohol is a farce. But you know that already."
Environmental Science and Research bioanalytical programme manager Dr Paul Fitzmaurice made his point in a February 17 email.
"If the government is accepting of the higher harm associated with alcohol and tobacco, then the applying of a different metric to new substances would imply that the current legislation is incorrect."
In reply, ministry policy analyst Mark Heffernan wrote that he would be "uneasy" about aligning the safety tolerance factor with alcohol, "due to the substantial harm that alcohol can cause".
"This would be a hard sell and I think it will be necessary to set the bar for approval at a level that alcohol would not meet."
The documents also reveal that synthetic cannabis is unlikely to be approved in smokable form because of concerns about cancer and dosage.
But other drugs, including hallucinogens, could be deemed "low risk" and on sale by around 2014.
The Ministry of Health rejected one unnamed health professional's advice that hallucinogens should be automatically rejected.
It noted that experts, including former British Government adviser Professor David Nutt, had identified LSD as low-risk compared to other recreational drugs.
"A challenge we will face therefore is what happens should an 'LSD like' drug be submitted for approval under the proposed new regime," Mr Heffernan wrote in a February 8 email.
"If this product's potential to induce hallucinations immediately lead to the abandonment of a trial, then the true harm of such a substance, which could in theory be relatively low, will be difficult to ascertain."
Officials at Mr Dunne's office could not be reached for comment yesterday, but NZ Drug Foundation executive director Ross Bell said there were inconsistencies in society's approach to alcohol.
"This hypocrisy that we have in the policy frameworks is seen very starkly by young people.
"Parents are saying the drug that you smoke or the pills that you take are terribly bad. But the drink that I can buy from the supermarket that causes billions of dollars more damage is okay."
But he said political realities meant a "one size fits all" drug policy was not likely, and the psychoactive drug reforms should be applauded.
"The Government has turned away from the sledge-hammer of prohibition, to recognising it can take greater control over that part of the drug market.
Alcohol Action NZ spokesman Dr Geoffrey Robinson said alcohol was a huge cost for hospitals and emergency departments.
"Most hospital departments have got some alcohol-related problems, whether it's the brain, the liver, pancreas or cardiac problems."
Dr Robinson said there was also a direct cost incurred by the public health system from violent assaults that resulted in injuries.
Legal-system costs from alcohol-related issues were also substantial.
- Nicholas Jones, NZ Herald